Average Co-Inventor Count = 6.22
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (13 from 3,923 patents)
2. Aventis Pharma Deutschland, Gmbh (6 from 330 patents)
3. Sanofi-a Ventis Deutschland Gmbh (5 from 1,829 patents)
4. Sanofi (3 from 1,454 patents)
5. Sanofi-aventis (1 from 389 patents)
6. Aventis Pharmaceuticals Inc. (1 from 207 patents)
7. Bausch + Lomb Ireland Limited (1 from 31 patents)
31 patents:
1. 12435040 - 1,3-substituted cyclobutyl derivatives and uses thereof
2. 12084442 - Naphthyridinone derivatives for the treatment of a disease or disorder
3. 11845730 - 1,3-substituted cyclobutyl derivatives and uses thereof
4. 11530213 - Naphthyridinone derivatives and their use in the treatment of arrhythmia
5. 10844055 - Naphthyridinone derivatives and their use in the treatment of arrhythmia
6. 10266531 - Naphthyridinone derivatives and their use in the treatment of arrhythmia
7. 10058534 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
8. 9931317 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
9. 9561211 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
10. 9546138 - Pyridone derivatives and uses thereof in the treatment of tuberculosis
11. 9409871 - Pyridazinyl derivatives as SMO inhibitors
12. 9321746 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
13. 8877801 - Compounds and compositions as selective estrogen receptor degraders
14. 8722671 - Isoquinoline derivatives
15. 8710228 - Cycloalkylamine substituted isoquinoline derivatives